Anest. intenziv. Med. 2007;18(3):170-174

Monocyte activation during the first days in the ICU and survival in a heterogeneous group of patients requiring long-term intensive careIntensive Care Medicine - Original Paper

L. Dadák1, M. Štouračová2, P. Štětka1, P. Kuklínek2, V. Šrámek1
1 Anesteziologicko-resuscitační klinika Fakultní nemocnice u svaté Anny v Brně
2 Ústav klinické imunologie a alergologie Fakultní nemocnice u svaté Anny v Brně

Objective:
To establish the predictive value of monocyte activation during the initial ICU days on the ICU survival of patients requiring long-term intensive care.

Design:
Prospective, clinical study.
Setting:
Department Anaesthesia and Intensive Care, St. Anna University Hospital, Brno, Czech Republic.

Material and methods:
The immune profile was taken in patients estimated to stay in the ICU > 3 days in 5-day intervals. In this paper we report on activation of monocytes (Dr locus expression i.e. CD14+HLA-DR+) determined by flow-cytometry during the first 5 days of ICU stay.We study the relation of CD14+HLA-DR+ to ICU survival, type of admission (surgical, medical, trauma, CPR) and APACHE II.

Results:
147 patients were studied [M/F 106/41; mean age 63 (54; 73) years]. 123 survived their ICU stay (S) and 24 died (NS). APACHE II on admission was 27 (20; 32). On day1 the CD14+HLA-DR+ was not different in S and NS [62% (45; 76) and 62.5% (42; 82) respectively; p = 0.92] and its trend from day 1 to day 5 did not differ either [delta CD14+HLA-DR+ 18%(5; 32) and 5% (-23; 35)%, respectively; p = 0.19]. Surgical patients had significantly lower CD14+HLA-DR+ on admission compared to medical and CPR patients (p < 0.002 and p < 0.0002 respectively). No correlation was found between CD14+HLA-DR+ and APACHE II on admission (R = 0.015, p = 0.84).

Conclusion:
Monocyte activation (CD14+HLA-DR+) on admission to ICU and its trend until ICU day 5 do not predict ICU mortality in the heterogeneous population of long-term ICU patients.

Keywords: intensive; immunoparalysis; monocytes; APACHE II; outcome

Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dadák L, Štouračová M, Štětka P, Kuklínek P, Šrámek V. Monocyte activation during the first days in the ICU and survival in a heterogeneous group of patients requiring long-term intensive care. Anest. intenziv. Med. 2007;18(3):170-174.
Download citation

References

  1. Demoule, A., Cracco, C., Lefort,Y., Ray, P., Derenne, J. P., Similowski, T. Patients aged 90 years or older in the intensive care unit. J. Gerontol. Biol. Sci. Med. Sci., 2005, 60, p. 129-132. Go to original source... Go to PubMed...
  2. Reinikainen, M., Niskanen, M., Uusaro, A., Ruokonen, E. Impact of gender on treatment and outcome of ICU patients. Acta Anaesthesiol Scand., 2005, 49, p. 984-990. Go to original source... Go to PubMed...
  3. Peake, S. L., Moran, J. L., Ghelani, D. R., Lloyd, A. J., Walker, M. J. The effect of obesity on 12-month survival following admission to intensive care: A prospective study. Crit. Care Med., 2006, 34, p. 2929-2939. Go to original source... Go to PubMed...
  4. du Cheyron, D., Bouchet, B., Parienti, J. J., Ramakers, M., Charbonneau, P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med., 2005, 31, p. 1693-1699. Go to original source... Go to PubMed...
  5. Christmas, A. B., Wilson, A. K., Franklin, G. A., Miller, F. B., Richardson, J. D., Rodriguez, J. L. Cirrhosis and trauma: a deadly duo. Am. Surg., 2005, 71. p. 996-1000. Go to original source... Go to PubMed...
  6. Lima, E. Q., Dirce, M.T., Castro, I.,Yu, L. Mortality risk factors and validation of severity scoring systems in critically ill patients with acute renal failure. Ren. Fail., 2005, 27, p. 547-556. Go to original source... Go to PubMed...
  7. Norena, M., Wong, H., Thompson, W. D., Keenan, S. P., Dodek, P. M. Adjustment of intensive care unit outcomes for severity of illness and comorbidity scores. J. Crit. Care, 2006, 21, p. 142-150. Go to original source... Go to PubMed...
  8. Bagshaw, S. M., Mortis, G., Doig, C. J., Godinez-Luna, T., Fick, G. H., Laupland, K. B. One-year mortality in critically ill patients by severity of kidney dysfunction: a population-based assessment. Am. J. Kidney Dis., 2006, 48, p. 402-409. Go to original source... Go to PubMed...
  9. Poeze, M., Solberg, B. C., Greve, J. W, Ramsay, G. Monitoring global volume-related hemodynamic or regional variables after initial resuscitation: What is a better predictor of outcome in critically ill septic patients? Crit. Care Med., 2005, 33, p. 2494-2500. Go to original source... Go to PubMed...
  10. Rivers, E., Nguyen, B., Havstad, S. et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med., 2001, 345, p. 1368-1377. Go to original source... Go to PubMed...
  11. Nguyen, H. B., Rivers, E. P., Knoblich, B. P. et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit. Care Med., 2004, 32, p. 1637-1642. Go to original source... Go to PubMed...
  12. Suistomaa, M., Ruokonen, E., Kari, A., Takala, J. Time-pattern of lactate and lactate to pyruvate ratio in the first 24 hours of intensive care emergency admissions. Shock, 2000, 14, p. 8-12. Go to original source... Go to PubMed...
  13. Friedman, G., Berlot, G., Kahn, R. J., Vincent, J. L. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit. Care Med., 1995, 23, p. 1184-1193. Go to original source... Go to PubMed...
  14. Husain, F. A., Martin, M. J., Mullenix, P. S. et al. Serum lactate and base deficit as predictors of mortality and morbidity. Am. J. Surg., 2003, 185, p. 485-491. Go to original source... Go to PubMed...
  15. Holtfreter, B., Bandt, C., Kuhn, S. O. et al. Serum osmolality and outcome in intensive care unit patients. Acta Anaesthesiol Scand., 2006, 50, p. 970-977. Go to original source... Go to PubMed...
  16. Bochicchio, G. V., Salzano, L., Joshi, M. et al. Admission preoperative glucose is predictive of morbidity and mortality in trauma patients who require immediate operative intervention. Am. Surg., 2005, 71, p. 171-174. Go to original source... Go to PubMed...
  17. King, D. A., Codish, S., Novack, V., Barski, L., Almog, Y. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit. Care, 2005, 9, p. R390-395. Go to original source... Go to PubMed...
  18. Knaus, W. A., Draper, E. A., Wagner, D. P., Zimmerman, J. E. APACHE II: a severity of disease classification system. Crit. Care Med., 1985, 13, p. 818-829. Go to original source... Go to PubMed...
  19. Moreno, R. P., Metnitz, P. G., Almeida, E.et al. SAPS 3 - from evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med., 2005, 31, p. 1345-55. Go to original source... Go to PubMed...
  20. McCallion, K., McAuley, D. F., Harkin, D. W. et al. Phagocyte priming as a prognostic indicator in the intensive care unit. J. Trauma, 2003, 55, p. 1089-1094. Go to original source... Go to PubMed...
  21. Taniguchi, T., Koido, Y., Aiboshi, J. et al. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit. Care Med. 1999, 27, p. 1262-1264. Go to original source... Go to PubMed...
  22. Watanabe, E., Hirasawa, H., Oda, S. et al. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J. Trauma, 2005, 59, p. 1181-1189. Go to original source... Go to PubMed...
  23. Meduri, G. U., Headley, S., Kohler, G.et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest, 1995, 107, p. 1062-1073. Go to original source... Go to PubMed...
  24. Holzheimer, R. G., Capel, P., Cavaillon, J. M.et al. Immunological surrogate parameters in a prognostic model for multi-organ failure and death. Eur. J. Med. Res., 2000, 5, p. 283-294.
  25. Stimac, D., Fisic, E., Milic, S. et al. Prognostic values of IL-6, IL-8, and IL-10 in acute pancreatitis. J. Clin. Gastroenterol., 2006, 40, p. 209-212. Go to original source... Go to PubMed...
  26. Friedland, J. S., Porter, J. C., Daryanani, S. et al. Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit. Care Med., 1996, 24, p. 1775-1781. Go to original source... Go to PubMed...
  27. Spolarics, Z., Siddiqi, M., Siegel, J. H. et al. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit. Care Med., 2003, 31, p. 1722-1729. Go to original source... Go to PubMed...
  28. Nierhaus, A., Schneider, C. G., Frings, D. et al. Sequential assessment of immune function in SIRS and sepsis: monocyte function, severity and outcome. Intensive Care Med., 2001, 27, S2, p. S199.
  29. Nierhaus, A., Montag, B., Timmler, N. et al. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med., 2003, 29, p. 646-651. Go to original source... Go to PubMed...
  30. Monneret, G., Lepape, A., Voirin, N. et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med., 2006, 32, p. 1175-1183. Go to original source... Go to PubMed...
  31. Průcha, M., Herold, I., Zazula, R. et al. Monocytární deaktivace a produkce tumor nekrotizujícího faktoru ex vivo - prognostické parametry pacientů jednotek intenzivní péče. Anest. intenziv. Med., 2003, 14, s. 223-227.
  32. Monneret, G., Finck, M. E., Venet, F. et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol. Lett., 2004. 95, p. 193-198. Go to original source... Go to PubMed...
  33. Ploder, M., Pelinka, L., Schmuckenschlager, C. et al. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock, 2006, 25, p. 129-134. Go to PubMed...
  34. Oczenski, W., Krenn, H., Jilch, R. et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med., 2003, 29, p. 1253-1257. Go to original source... Go to PubMed...
  35. Allen, M. L., Peters, M. J., Goldman, A. et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit. Care Med., 2002, 30, p. 1140-1145. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.